These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8818571)

  • 21. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
    Cundy KC
    Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of partial retinal destruction and gliosis on the intravitreal pharmacokinetics of HPMPC.
    Kim JW; el-Haig W; Capparelli EV; Besen G; Connor JD; Freeman WR
    Retina; 1995; 15(6):513-7. PubMed ID: 8747447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl ester prodrugs of cyclic HPMPC. I: Physicochemical characterization and in vitro biological stability.
    Oliyai R; Shaw JP; Sueoka-Lennen CM; Cundy KC; Arimilli MN; Jones RJ; Lee WA
    Pharm Res; 1999 Nov; 16(11):1687-93. PubMed ID: 10571273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system.
    Moore MR; Hamzeh FM; Lee FE; Lietman PS
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2404-8. PubMed ID: 7840578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine.
    Dolnak DR; Munguia D; Wiley CA; De Clercq E; Bergeron-Lynn GL; Boscher C; Connor JD; Sherwood C; Capparelli E; Armani R
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1557-63. PubMed ID: 1559752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cidofovir plasma assays after local injection in respiratory papillomatosis.
    Naiman AN; Roger G; Gagnieu MC; Bordenave J; Mathaut S; Ayari S; Nicollas R; Bour JB; Garabedian N; Froehlich P
    Laryngoscope; 2004 Jul; 114(7):1151-6. PubMed ID: 15235339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney.
    Ciesla SL; Trahan J; Wan WB; Beadle JR; Aldern KA; Painter GR; Hostetler KY
    Antiviral Res; 2003 Aug; 59(3):163-71. PubMed ID: 12927306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
    Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
    Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
    Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studies.
    Zakharova VM; Serpi M; Krylov IS; Peterson LW; Breitenbach JM; Borysko KZ; Drach JC; Collins M; Hilfinger JM; Kashemirov BA; McKenna CE
    J Med Chem; 2011 Aug; 54(16):5680-93. PubMed ID: 21812420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys.
    Lacy SA; Hitchcock MJ; Lee WA; Tellier P; Cundy KC
    Toxicol Sci; 1998 Aug; 44(2):97-106. PubMed ID: 9742650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cidofovir (HPMPC) potent against CMV.
    Posit Aware; 1995; ():5. PubMed ID: 11362567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats.
    Shaw JP; Louie MS; Krishnamurthy VV; Arimilli MN; Jones RJ; Bidgood AM; Lee WA; Cundy KC
    Drug Metab Dispos; 1997 Mar; 25(3):362-6. PubMed ID: 9172955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The activity of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine (HPMPC) against equine herpesvirus-1 (EHV-1) in cell cultures, mice and horses.
    Gibson JS; Slater JD; Field HJ
    Antiviral Res; 1992 Sep; 19(3):219-32. PubMed ID: 1332605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria.
    Polis MA; Spooner KM; Baird BF; Manischewitz JF; Jaffe HS; Fisher PE; Falloon J; Davey RT; Kovacs JA; Walker RE
    Antimicrob Agents Chemother; 1995 Apr; 39(4):882-6. PubMed ID: 7785989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in Vero cells.
    Connelly MC; Robbins BL; Fridland A
    Biochem Pharmacol; 1993 Sep; 46(6):1053-7. PubMed ID: 8216348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.